Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
BMJ Open|June 20, 2025
Reproducibility of published model-based cancer drug cost-effectiveness analyses: a study protocol for a cross-sectional analysisMikael Svensson, Jonathan Siverskog, Naimi Johansson, et al.
Drug and Alcohol Dependence|August 17, 2024
Effects of a waiting list control design on alcohol consumption among online help-seekers: A randomised controlled trialKatarina Ulfsdotter Gunnarsson, Martin Henriksson, Jim McCambridge, et al.
JAMA Dermatology|June 4, 2020
Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish StudyKirk Geale, Martin Henriksson, Jussi Jokinen, et al.
Cancer Research|November 3, 2023
Targeting MTHFD2 to Exploit Cancer-Specific Metabolism and the DNA Damage ResponseLouise Ramos, Martin Henriksson, Thomas Helleday, et al.
Journal of Clinical Epidemiology|August 25, 2020
The transfer of clinical prediction models for early trauma care had uncertain effects on mistriageMartin Henriksson, Dell D Saulnier, Johanna Berg, et al.
Archives of Physical Medicine and Rehabilitation|January 1, 2008
Cost-effectiveness of C-leg compared with non-microprocessor-controlled knees: a modeling approachThor-Henrik Brodtkorb, Martin Henriksson, Kasper Johannesen-Munk, et al.
Scandinavian Cardiovascular Journal : SCJ|March 22, 2014
Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and DenmarkMartin Henriksson, Elisabet Nikolic, Audun Ohna, et al.
Primary Care Diabetes|October 18, 2011
Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in SwedenOla Granström, Klas Bergenheim, Phil McEwan, et al.
European Heart Journal|June 22, 2012
Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO studyElisabet Nikolic, Magnus Janzon, Ole Hauch, et al.
Hepatology Communications|June 22, 2023
Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver diseaseLina Gruneau, Stergios Kechagias, Per Sandström, et al.
Pageof 8